Bornyl Acetate
Active ingredient
Sold as LINDOFLUID
- Drug class
- -
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Bornyl Acetate is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | October 10, 2025 |
GBUnited Kingdom· MHRA
1 product
Uses
For the symptomatic relief of muscular pain and stiffness including backache, lumbago, fibrositis, cramp and bruising.
How to take
Posology Apply sparingly to the affected part four times a day. Lightly massage if necessary.
Paediatric population Children under 6 years:
Not to be used. Method of administration For external use only.
This is not medical advice. Consult a qualified healthcare professional.
Side effects & warnings
Irritant skin reactions may occur in the presence of turpentine oil. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellowcard.
• Not to be used on broken skin. • Avoid contact with eyes and mucous membranes. • If conditions worsen or persist, seek medical advice. • If pregnant or lactating, consult a physician before using.
This is not medical advice. Consult a qualified healthcare professional.
Who should not take it
1.
This is not medical advice. Consult a qualified healthcare professional.
Brands in United Kingdom (1)
Sources & citations
- [1]MHRA (UK) · PL113110532 · revised October 10, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.